For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Pamela Crilley

Pamela Crilley, DO


Department: Medicine: Division of Hematology/Oncology

Specialties: Hematology / Oncology


  • DO - Philadelphia College of Osteopathic Medicine (1979)
  • BA in English Literature - Temple University (1974)
  • English Literature - Beloit College (1969)

Pamela Crilley, DO, is a hematologist and medical oncologist practicing in Center City Philadelphia. She is board certified in internal medicine, with subspecialty certification in hematology and medical oncology.

She previously served as director of the Controlled Environment Oncology Unit and clinical program director of the Blood and Marrow Program at Hahnemann University Hospital.


  • American Society of Hematology
  • American Society of Clinical Oncology
  • International Society for Experimental Hematology 
  • Eastern Cooperative Oncology Group
  • Philadelphia Bone Marrow Transplant Group
  • American Society for Blood and Marrow Transplantation
  • American Medical Association
  • Fellow, College of Physicians of Philadelphia
  • Philadelphia County Medical Society
  • Advisory Council of the Bone Marrow Foundation

Awards and Honors

  • Best Doctors in America, 2005-2008, 2010-2011
  • Battafarano Award for Excellence in Clinical Care, 1996

Clinical Services

Internal medicine, Hematology, Oncology, Medical oncology


  • Hematology/Oncology - Hahnemann University Hospital (1985)


  • Internal Medicine - Delaware Valley Medical Center (1982)


  • Rotating Internship - Delaware Valley Medical Center (1980)

Dr. Crilley is a professor of medicine at Drexel University College of Medicine. Her teaching responsibilities include:

  • Lectures on leukemia and lymphoma, hematology workshops and ethics seminars for the Introduction to Clinical Medicine course
  • Teaching medical students, interns, residents and fellows about leukemia/lymphoma and marrow transplant service
  • Instructing medical residents on breast cancer, leukemia, lymphoma, and bone marrow transplantation as part of the core curriculum


Book Chapters

"Cancer Chemotherapy"
Crilley P and Styler M
Basic Pharmacology in Medicine, 4th edition, 1994

"Testicular Cancer"
Crilley P
Laboratory Medicine: The Selection and Interpretation of Clinical Laboratory Studies (eds. Noe, D.A., and Rock, R.C.), Chapter 41, pp. 858 - 862, 1994

"Cancer Chemotherapy"
Brodsky I, Crilley P, and Terzian A
Basic Pharmacology in Medicine, pp. 549-565, March 1990

"The Leukemias"
Olshan T, Crilley P, Kahn SB
Principles and Practice of Radiation Oncology (eds. C.A. Perez and L. Brady), Chapter 59, pp. 1101-1107, 1987

Recent Abstracts

"Mean Platelet Volume Predicts Platelet Engraftment Post Hematopoietic Stem Cell Transplantation"
W Dhillon, MD, P Lothe, MD, K Ward, MD, P Crilley, DO, D Topolsky, MD, M Styler, MD
Blood, 122: 5507, October 2013

"Significance of Missing Inhibitory KIR Ligands in Nonmyeloablative, HLA-Haploidentical (Haplo) BMT with Posttransplantation High-Dose Cyclophosphamide (PT/Cy)"
Kasamon YL, Luznik L, Leffell MS, Tsai HL, Symons HJ, Bolanos-Meade J, Rosner G, Morris LE, Crilley P, Jones RJ, Fuchs EJ
Blood (ASH Annual Meeting Abstracts): Abstract 840, 2011

"Prognostic factors of long-term survival in patients with acute myeloid leukemia after allogeneic or autologous stem cell transplantation"
Wang L, Corona C, Xingcao N, Mejias L, Hou S, Mullaney R, Ward K, Topolsky D, Styler M, Crilley P
J. Clin. Oncology, ASCO Annual Meeting Proceedings, Vol 29, I of II Abstract 6594, June 2011

"G-CSF Dose Escalation Starting Day 8 after Salvage RICE Chemotherapy Results in Adequate and Predictable Autologous Peripheral Blood Stem Cell Collection in Relapsed/Refractory Lymphoma"
A Weber, P Pillai, M Styler, D Topolsky, K Ward, R Mullaney, P Crilley
Biology of Blood and Marrow Transplantation, Vol. 17, No. 2 Abstract #148, February 2011

"Invasive Rhino-Cerebral Mucormycosis"
P Pillai, P Crilley, K Ward, D Topolsky, M Styler
Manuscript Draft submitted to: Elsevier Editorial System™ for The Lancet Infectious Disease

"Chronic GVHD presenting as Delayed Onset Polymyositis after Allogeneic Bone Marrow Transplantation"
P Pillai, R Vatanparast, A Weber, JM Kane, M Styler, D Topolsky, K Ward, R Mullaney, CD Katsetos, P Crilley
Abstract # 70057, BMT Tandem Meeting, 2011

"Evaluation of the Pre-Test Scoring System (4Ts) for the Evaluation and Management of Heparin Induced Thrombocytopenia"
R Vatanparast, P Pillai, G Crane, S Minter, K Ward, D Topolsky, M Styler, P Crilley
ASH Abstract #26816, ASH Presentation, December 4-7, 2010

"Validation of the European Practice Guidelines for the Use of Recombinant Activated Factor VII in Patients with Massive Bleeding"
P Pillai, R Ranganathan, R Vatanparast, R Reddimallu, S Lantz, L Bachegowda, K Ward, M Styler, D Topolsky, P Crilley
ASH Abstract #32260, ASH Presentation, December 4-7, 2010
Poster Presentation #122, Drexel Discovery Day, September 2010

"Clinical and pathologic outcome analysis with the preoperative systemic therapy in operable breast cancer"
P Pillai, Y Ma, VK Sandilya, J Innocent, RR Rubin, N Popnikolov, D Topolsky, P Crilley, L Newman, M Styler
J. Clin Oncology 28, (suppl; abstr e11094), 2010

"Haplo Identical (Partially HLA Mismatched, Related Donor) Non-Myeloablative Bone Marrow Transplantation: Hahnemann University Hospital Experience"
P Pillai, M Styler, D Topolsky, K Ward, R Mullaney, K Skinner, P Crilley
DrexelMed Journal, Volume 4 (1); Summer 2010
Poster Presentation # 118, Drexel Discovery Day, Sept 2009

Recent Publications

"Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia"
Kasamon YL, Brodsky RA, Borowitz MJ, Ambinder RF, Crilley PA, Cho SY, Tsai HL, Smith BD, Gladstone DE, Carraway HE, Huff CA, Matsui WH, Bolaños-Meade J, Jones RJ, Swinnen LJ
Leuk Lymphoma, Volume 54 (3), March 2013.

"Evaluation of a Pretest Scoring System (4Ts) for the Diagnosis of Heparin-Induced Thrombocytopenia in a University Hospital Setting"
R Vatanparast, MD, S Lantz, DO, K Ward, MD, P Crilley, DO, M Styler, MD
Postgrad Medicine, Volume 124 (6), November 2012.

"Improved Clinical Outcomes with the Application of the 4T score in evaluating and managing Type II HIT; A multi-disciplinary educational approach"
Vatanparast R, Lantz S, Innocent J, Styler M, Crilley P
Submitted to Annals of Internal Medicine, June 2011

"Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome"
Kasamon Y, Luznik L, Leffell MS, Kowalski J, Tsai HL, Bolaños-Meade J, Morris LE, Crilley P, O’Donnell PV, Rossiter N, Huff CA, Brodsky RA, Matsui WH, Swinnen LJ, Borrello I, Powell JD, Ambinder RF, Jones RJ, Fuchs EJ
Biology Blood Marrow Transplant 16: 482-489, 2010

"High-dose cyclophosphamide in the Treatment of Multiple Sclerosis"
Schwartzman RJ, Simpkins N, Alexander GM, Reichenberger E, Ward K, Lindenberg N, Topolsky D, Crilley P
CNS Neuroscience & Therapeutics 15, 118-127, 2009

"Late Mortality and Relapse following BuCy2 and HLA-identical Sibling Marrow Transplantation for Chronic Myelogenous Leukemia"
Copelan E, Crilley P, Szer J, Dodds AJ, Stevenson D, Phillips G, Nivison-Smith I, Avalos BR, Penza S, Topolsky D, Sobecks R, Kalaycio M, Bolwell BJ
Biology Blood Marrow Transplant 15:851-855, 2009